{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:50:14Z","timestamp":1761709814292,"version":"3.44.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012112","name":"Swedish Orphan Biovitrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012112","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.clp.2020.11.008","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T23:07:44Z","timestamp":1610492864000},"page":"167-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Histiocytic Diseases of Neonates"],"prefix":"10.1016","volume":"48","author":[{"given":"Kenneth L.","family":"McClain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.clp.2020.11.008_bib1","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.4049\/jimmunol.0902336","article-title":"Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells","volume":"184","author":"Allen","year":"2010","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.clp.2020.11.008_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/pbc.20725","article-title":"Fetal and neonatal histiocytoses","volume":"47","author":"Isaacs","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1016\/j.clp.2020.11.008_bib3","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1056\/NEJMra1607548","article-title":"Langerhans-cell histiocytosis","volume":"379","author":"Allen","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1016\/j.clp.2020.11.008_bib4","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1182\/blood-2012-09-455774","article-title":"Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis","volume":"121","author":"Gadner","year":"2013","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.clp.2020.11.008_bib5","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1200\/JCO.2015.65.9508","article-title":"BRAF mutation correlates with high-risk Langerhans cell histiocytosis and increased resistance to first line therapy","volume":"34","author":"Heritier","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.clp.2020.11.008_bib6","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clp.2020.11.008_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/pbc.21498","article-title":"Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004","volume":"51","author":"Guyot-Goubin","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.clp.2020.11.008_bib8","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/pbc.25404","article-title":"Ethnicity, race, and socioeconomic status influence incidence of Langerhans cell histiocytosis","volume":"62","author":"Ribeiro","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"20","key":"10.1016\/j.clp.2020.11.008_bib9","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood-2017-08-800565","article-title":"A\u00a0genome-wide association study of LCH identifies a variant in SMAD6 associated with susceptibility","volume":"130","author":"Peckham-Gregory","year":"2017","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.clp.2020.11.008_bib10","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1084\/jem.20071733","article-title":"Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state","volume":"204","author":"Ginhoux","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.clp.2020.11.008_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/B978-0-12-417028-5.00005-3","article-title":"Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases","volume":"120","author":"Berres","year":"2013","journal-title":"Adv Immunol"},{"issue":"3","key":"10.1016\/j.clp.2020.11.008_bib12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM199407213310303","article-title":"Langerhans'-cell histiocytosis (histiocytosis X): a clonal proliferative disease","volume":"331","author":"Willman","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.clp.2020.11.008_bib13","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2014-05-577825","article-title":"Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis","volume":"124","author":"Chakraborty","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clp.2020.11.008_bib14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1084\/jem.20161881","article-title":"RAF\/MEK\/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions","volume":"215","author":"Hogstad","year":"2018","journal-title":"J\u00a0Exp Med"},{"issue":"8","key":"10.1016\/j.clp.2020.11.008_bib15","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1371\/journal.pmed.0040253","article-title":"Expansion of regulatory T\u00a0cells in patients with Langerhans cell histiocytosis","volume":"4","author":"Senechal","year":"2007","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.clp.2020.11.008_bib16","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20130977","article-title":"BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups","volume":"211","author":"Berres","year":"2014","journal-title":"J\u00a0Exp Med"},{"issue":"5","key":"10.1016\/j.clp.2020.11.008_bib17","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.hoc.2015.06.001","article-title":"Nosology and pathology of Langerhans cell histiocytosis","volume":"29","author":"Picarsic","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"issue":"7","key":"10.1016\/j.clp.2020.11.008_bib18","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/pbc.22229","article-title":"2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). Results of the LCH-S-98 protocol of the Histiocyte Society","volume":"53","author":"Weitzman","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.clp.2020.11.008_bib19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/pbc.24772","article-title":"Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease","volume":"61","author":"Simko","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.clp.2020.11.008_bib20","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1002\/pbc.24436","article-title":"Clofarabine salvage therapy for refractory high-risk Langerhans cell histiocytosis","volume":"60","author":"Abraham","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"15","key":"10.1016\/j.clp.2020.11.008_bib21","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood-2018-10-878363","article-title":"Clinical responses and persistent BRAF V600E(+) blood cells in children with LCH treated with MAPK pathway inhibition","volume":"133","author":"Eckstein","year":"2019","journal-title":"Blood"},{"issue":"31","key":"10.1016\/j.clp.2020.11.008_bib22","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1200\/JCO.19.00456","article-title":"Vemurafenib for refractory multisystem Langerhans cell histiocytosis in children: an international observational study","volume":"37","author":"Donadieu","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.clp.2020.11.008_bib23","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/bjh.13347","article-title":"Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning","volume":"169","author":"Veys","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clp.2020.11.008_bib24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/mpo.1306","article-title":"Cholestasis, sclerosing cholangitis, and liver transplantation in Langerhans cell histiocytosis","volume":"38","author":"Braier","year":"2002","journal-title":"Med Pediatr Oncol"},{"issue":"8","key":"10.1016\/j.clp.2020.11.008_bib25","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1002\/ppul.24822","article-title":"Management of severe pulmonary Langerhans cell histiocytosis in children","volume":"55","author":"Eckstein","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.clp.2020.11.008_bib26","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/pbc.20425","article-title":"Risk factors for diabetes insipidus in Langerhans cell histiocytosis","volume":"46","author":"Grois","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.clp.2020.11.008_bib27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jpeds.2003.12.030","article-title":"Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study","volume":"144","author":"Donadieu","year":"2004","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.clp.2020.11.008_bib28","first-page":"1169","article-title":"Adenitis with lipid excess, in children or young adults, seen in the Antilles and in Mali. (4 cases)","volume":"58","author":"Destombes","year":"1965","journal-title":"Bull Soc Pathol Exot Filiales"},{"issue":"1","key":"10.1016\/j.clp.2020.11.008_bib29","first-page":"63","article-title":"Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity","volume":"87","author":"Rosai","year":"1969","journal-title":"Arch Pathol"},{"issue":"3","key":"10.1016\/j.clp.2020.11.008_bib30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/pbc.21880","article-title":"Congenital Rosai-Dorfman disease presenting with anemia, thrombocytopenia, and hepatomegaly","volume":"52","author":"Chow","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.clp.2020.11.008_bib31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3109\/08880019609030873","article-title":"Steroid-responsive Rosai-Dorfman disease","volume":"13","author":"Antonius","year":"1996","journal-title":"Pediatr Hematol Oncol"},{"year":"2020","author":"McClain","article-title":"Peripheral lymphadenopathy in children: evaluation and diagnostic approach","key":"10.1016\/j.clp.2020.11.008_bib32"},{"issue":"26","key":"10.1016\/j.clp.2020.11.008_bib33","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1182\/blood-2018-03-839753","article-title":"Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease","volume":"131","author":"Abla","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clp.2020.11.008_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12185-008-0192-2","article-title":"Extranodal multifocal Rosai-Dorfman disease: response to 2-chlorodeoxyadenosine treatment","volume":"89","author":"Konca","year":"2009","journal-title":"Int J Hematol"},{"issue":"2","key":"10.1016\/j.clp.2020.11.008_bib35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0022-3476(96)70247-0","article-title":"Juvenile xanthogranuloma: forms of systemic disease and their clinical implications","volume":"129","author":"Freyer","year":"1996","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.clp.2020.11.008_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.pas.0000147395.01229.06","article-title":"Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the Kiel pediatric tumor registry","volume":"29","author":"Janssen","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.clp.2020.11.008_bib37","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s41591-019-0653-6","article-title":"Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms","volume":"25","author":"Durham","year":"2019","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.clp.2020.11.008_bib38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3928\/0191-3913-19910501-10","article-title":"Limbal xanthogranuloma","volume":"28","author":"Collum","year":"1991","journal-title":"J\u00a0Pediatr Ophthalmol Strabismus"},{"issue":"3","key":"10.1016\/j.clp.2020.11.008_bib39","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1067\/moe.2002.122340","article-title":"Juvenile xanthogranuloma of the oral cavity in children: a clinicopathologic study","volume":"94","author":"Flaitz","year":"2002","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"2","key":"10.1016\/j.clp.2020.11.008_bib40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ppul.20544","article-title":"Managing isolated subglottic juvenile xanthogranuloma without tracheostomy: case report and review of literature","volume":"42","author":"Somorai","year":"2007","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.clp.2020.11.008_bib41","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/pbc.22629","article-title":"Juvenile xanthogranuloma with hematological dysfunction treated with 2CDA-AraC","volume":"55","author":"Blouin","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.clp.2020.11.008_bib42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/pbc.20514","article-title":"Prolonged severe pancytopenia preceding the cutaneous lesions of juvenile xanthogranuloma","volume":"47","author":"Hara","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.clp.2020.11.008_bib43","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41379-018-0168-6","article-title":"ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion","volume":"32","author":"Chang","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clp.2020.11.008_bib44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/archderm.1975.01630150085012","article-title":"Juvenile xanthogranuloma and urticaria pigmentosa","volume":"111","author":"Morier","year":"1975","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.clp.2020.11.008_bib45","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1001\/archderm.1995.01690200040007","article-title":"Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis","volume":"131","author":"Zvulunov","year":"1995","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.clp.2020.11.008_bib46","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00043426-200406000-00007","article-title":"Successful treatment of congenital systemic juvenile xanthogranuloma with Langerhans cell histiocytosis-based chemotherapy","volume":"26","author":"Nakatani","year":"2004","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"2 Suppl","key":"10.1016\/j.clp.2020.11.008_bib47","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jaad.2007.09.012","article-title":"Disseminated juvenile xanthogranulomatosis in a newborn resulting in liver transplantation","volume":"58","author":"Haughton","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510820301354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510820301354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:58:38Z","timestamp":1758815918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510820301354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0095510820301354"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2020.11.008","relation":{},"ISSN":["0095-5108"],"issn-type":[{"type":"print","value":"0095-5108"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histiocytic Diseases of Neonates","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2020.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}